Clinical Trial Update: Effect of SGLT2 Inhibitors on Anemic CKD Patients

View source ↗

Summary

A clinical trial is evaluating the impact of SGLT2 inhibitors on anemia in patients with chronic kidney disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease

Snippet

Sponsor: Sohag University | Conditions: Anemia in CKD Patients | Status: NOT_YET_RECRUITING